BRANCH ATHEROMATOUS DISEASE
Clinical trials for BRANCH ATHEROMATOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new BRANCH ATHEROMATOUS DISEASE trials appear
Sign up with your email to follow new studies for BRANCH ATHEROMATOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested to stop small strokes from getting worse
Disease control CompletedThis study tested whether adding the drug tirofiban to standard aspirin treatment could better prevent stroke worsening and new strokes in people with a specific type of small artery blockage in the brain. It involved 970 patients in China who had recently experienced this type o…
Matched conditions: BRANCH ATHEROMATOUS DISEASE
Phase: PHASE4 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
New drug tested to stop stroke worsening and improve recovery
Disease control CompletedThis study tested whether a drug called tirofiban, given within 48 hours of a specific type of stroke, helps patients recover better than standard antiplatelet therapy. It involved 516 adults with a stroke caused by branch atheromatous disease (BAD), which often gets worse early …
Matched conditions: BRANCH ATHEROMATOUS DISEASE
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC